Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical...
-
Upload
valerie-bryant -
Category
Documents
-
view
223 -
download
3
Transcript of Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical...
![Page 1: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/1.jpg)
Lower the better; the case for glucose
Professor Taner DAMCIIstanbul University Cerrahpaşa Medical
School, TURKEY
![Page 2: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/2.jpg)
Epidemiology suggests high glucose is toxic
![Page 3: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/3.jpg)
Blood glucose and CV risk
N = 17,869 men, aged 40–64 years; follow-up 33 years
Brunner EJ et al.Diabetes Care. 2006;29:26-31.
*Relative to baseline group of all men with blood glucose <83 mg/dL
83 mg/dL
OGTT blood glucose (mg/dL)
54 72 108 90 126 144 162 180
1.6
1.2
0.8
0.4
0.0
-0.4
CHD mortality (log hazard
ratios)*
![Page 4: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/4.jpg)
Adjusted relative hazard of coronary heart disease in 1321 individuals without diabetes (A) and 1626 individuals with diabetes (B), adjusted for age, sex, and race and plotted on the log scale. All adjusted relative hazards are centered at hemoglobin A1c (HbA1c) = 5.2%, and the graphed lines are shown for the fifth to 95th percentiles of HbA1c level. The solid black line in A is from a single-knot linear spline model (knot at HbA1c = 4.6%). The dotted gray line is from a linear spline model with knots at the quintiles of HbA1c. In B, the solid black line is from a linear model; the gray dotted line is from a linear spline model with knots at the quintiles of HbA1c level. The normal range for HbA1c in persons without diabetes (4%-6%) is indicated by the dotted vertical lines in A. The current target for glycemic control in persons with diabetes (HbA1c = 7%) is indicated by the vertical dotted line in B.
Arch Intern Med. 2005 Sep 12;165(16):1910-6.
Adjusted relative hazard of coronary heart disease in 1321 individuals without diabetes (A) and 1626 individuals with diabetes (B)
![Page 5: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/5.jpg)
Diabetic milleu is a toxic soup with hyperglycemia, lipids, oxidative stress and
combination of drugs….
![Page 6: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/6.jpg)
Effect of postprandial hyperglycemia on the arterial wall
MealHyperglycemia
Hyperlipidemia
Haller H. Diab Res Clin Pract 1998;40:S43–S49.
Oxidative stress Endothelial damage
Atherosclerosis
![Page 7: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/7.jpg)
Adjusted Hazard Ratios for Self-Reported Diagnosed Diabetes and Coronary Heart Disease, Ischemic Stroke, and Death from Any Cause, According to the Baseline Glycated Hemoglobin
Value.
Selvin E et al. N Engl J Med 2010;362:800-811.
![Page 8: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/8.jpg)
BMJ. 2006 Jan 14;332(7533):73-8. Epub 2005 Dec 21
![Page 9: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/9.jpg)
Lowering glucose in a diabetic patient decreases macro and microvascular
complications.
![Page 10: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/10.jpg)
Glucose Control Study Summary UKPDS
The intensive glucose control policy maintained a lower HbA1c by mean 0.9 % over a median follow up of 10 years from diagnosis of type 2 diabetes with reduction in risk of:
12% for any diabetes related endpointp=0.029
25% for microvascular endpointsp=0.0099
16% for myocardial infarctionp=0.052
24% for cataract extractionp=0.046
21% for retinopathy at twelve yearsp=0.015
33% for albuminuria at twelve yearsp=0.000054
![Page 11: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/11.jpg)
Kaplan-Meier Curves for Four Prespecified Aggregate Clinical Outcomes
Holman RR et al. N Engl J Med 2008;359:1577-1589
![Page 12: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/12.jpg)
DCCT/EDIC Study Research Group.N Engl J Med. 2005;353:2643-53.
DCCT/EDIC: Intensive glucose control reduces long-term CV risk
42%(95% CI 9%–63%)
P = 0.02
57%(95% CI 12%–79%)
P = 0.02
Cumulative
incidence of any first
CV event
Cumulative
CV death,nonfatal
MI,stroke
Time (years) Time (years)
Conventional52 events
Intensive31 events
Conventional25 events
Intensive11 events
0
0.12
0.08
0.10
0.06
0.04
0.02
0 5 10 15 20
0
0.12
0.08
0.10
0.06
0.04
0.02
0 5 10 15 20
N = 1441 with type 1 diabetes
![Page 13: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/13.jpg)
Glucose Control at Baseline and during Follow-up, According to Glucose-Control Strategy
The ADVANCE Collaborative Group. N Engl J Med 2008;358:2560-2572
![Page 14: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/14.jpg)
Cumulative Incidences of Events, According to Glucose-Control Strategy
The ADVANCE Collaborative Group. N Engl J Med 2008;358:2560-2572
![Page 15: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/15.jpg)
Normoglycemia does not necessarily mean increased
hypoglycemia
![Page 16: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/16.jpg)
Hypoglycemia is a side effect of treatment not of good
metabolic control
![Page 17: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/17.jpg)
Annual Rates of Severe Hypoglycemia According to Treatment Assignment and Adverse Clinical Outcomes among Patients with Severe Hypoglycemia.
Zoungas S et al. N Engl J Med 2010;363:1410-1418.
![Page 18: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/18.jpg)
How about ACCORD ?
![Page 19: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/19.jpg)
Kaplan–Meier Curves for the Primary Outcome and Death from Any Cause.
The Action to Control Cardiovascular Risk in Diabetes Study Group. N Engl J Med 2008;358:2545-2559.
![Page 20: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/20.jpg)
Spline curves displaying the risk of all-cause mortality with the two treatment strategies over the range of average A1C from 6.0 to 9.0%. The curves represent the linear part of the proportional hazards models derived from values for intervals of average A1C from model 3. For clarity, the figure omits values <6 and >9%; 5% of deaths are excluded from this plot at the lower end and also at the ∼higher end of the A1C range, but these data are included in the models. The bold orange line represents the intensive treatment strategy group, the bold blue line represents the standard group, and the finer colored lines represent the 95% CIs for each group.
![Page 21: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/21.jpg)
![Page 22: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/22.jpg)
Change in HbA1c by group; two subsets can be created based on likely improvement
Can we predict future improvement in glycaemic control?.Diabetic Medicine 25 (2), 170-173 2008
![Page 23: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/23.jpg)
It is inappropriately intensive treatment “not good glycemic control” which increase the risk.
![Page 24: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/24.jpg)
We have to individualize diabetes treatment. Most of the time side effects
are a result of confectionary treatments.
![Page 25: Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.](https://reader036.fdocuments.in/reader036/viewer/2022062422/56649ec15503460f94bcc6b8/html5/thumbnails/25.jpg)
So we should achive as low HbA1c as possible in
an individual patient without causing
hypoglycemia and weight gain.
We have the tools.